Literature DB >> 21734404

Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.

Marcella Devoto1, Claudia Specchia, Marci Laudenslager, Luca Longo, Hakon Hakonarson, John Maris, Yael Mossé.   

Abstract

BACKGROUND: Neuroblastoma (NB) is an important childhood cancer with a strong genetic component related to disease susceptibility. Approximately 1% of NB cases have a positive family history. Following a genome-wide linkage analysis and sequencing of candidate genes in the critical region, we identified ALK as the major familial NB gene. Dominant mutations in ALK are found in more than 50% of familial NB cases. However, in the families used for the linkage study, only about 50% of carriers of ALK mutations are affected by NB.
METHODS: To test whether genetic variation may explain the reduced penetrance of the disease phenotype, we analyzed genome-wide genotype data in ALK mutation-positive families using a model-based linkage approach with different liability classes for carriers and non-carriers of ALK mutations.
RESULTS: The region with the highest LOD score was located at chromosome 2p23-p24 and included the ALK locus under models of dominant and recessive inheritance.
CONCLUSIONS: This finding suggests that variants in the non-mutated ALK gene or another gene linked to it may affect penetrance of the ALK mutations and risk of developing NB in familial cases.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21734404      PMCID: PMC3136385          DOI: 10.1159/000324843

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  9 in total

1.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

Review 2.  Modifier genes and protective alleles in humans and mice.

Authors:  Joseph H Nadeau
Journal:  Curr Opin Genet Dev       Date:  2003-06       Impact factor: 5.578

3.  Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele.

Authors:  T L McGee; M Devoto; J Ott; E L Berson; T P Dryja
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

4.  Joint modeling of linkage and association: identifying SNPs responsible for a linkage signal.

Authors:  Mingyao Li; Michael Boehnke; Goncalo R Abecasis
Journal:  Am J Hum Genet       Date:  2005-04-05       Impact factor: 11.025

5.  Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12p.

Authors:  Luca Longo; Emanuele Panza; Francesca Schena; Marco Seri; Marcella Devoto; Giovanni Romeo; Carla Bini; Giuseppe Pappalardo; Gian Paolo Tonini; Patrizia Perri
Journal:  Hum Hered       Date:  2007-02-22       Impact factor: 0.444

6.  A variant of spectrin low-expression allele alpha LELY carrying a hereditary elliptocytosis mutation in codon 28.

Authors:  J Randon; L Boulanger; J Marechal; M Garbarz; A Vallier; L Ribeiro; G Tamagnini; D Dhermy; J Delaunay
Journal:  Br J Haematol       Date:  1994-11       Impact factor: 6.998

Review 7.  Recent advances in neuroblastoma.

Authors:  John M Maris
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

8.  Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria.

Authors:  Laurent Gouya; Caroline Martin-Schmitt; Anne-Marie Robreau; Frederic Austerlitz; Vasco Da Silva; Patrick Brun; Sylvie Simonin; Said Lyoumi; Bernard Grandchamp; Carole Beaumont; Herve Puy; Jean-Charles Deybach
Journal:  Am J Hum Genet       Date:  2005-11-15       Impact factor: 11.025

9.  Identification of ALK as a major familial neuroblastoma predisposition gene.

Authors:  Yaël P Mossé; Marci Laudenslager; Luca Longo; Kristina A Cole; Andrew Wood; Edward F Attiyeh; Michael J Laquaglia; Rachel Sennett; Jill E Lynch; Patrizia Perri; Geneviève Laureys; Frank Speleman; Cecilia Kim; Cuiping Hou; Hakon Hakonarson; Ali Torkamani; Nicholas J Schork; Garrett M Brodeur; Gian P Tonini; Eric Rappaport; Marcella Devoto; John M Maris
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

  9 in total
  16 in total

Review 1.  The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.

Authors:  Raquel Domingo-Fernandez; Karen Watters; Olga Piskareva; Raymond L Stallings; Isabella Bray
Journal:  Pediatr Surg Int       Date:  2012-12-29       Impact factor: 1.827

2.  ALK expression, prognostic significance, and its association with MYCN expression in MYCN non-amplified neuroblastoma.

Authors:  Dinesh Babu Somasundaram; Sheeja Aravindan; Nandita Gupta; Zhongxin Yu; Ashley Baker; Natarajan Aravindan
Journal:  World J Pediatr       Date:  2022-02-07       Impact factor: 2.764

Review 3.  New insights into the genetics of neuroblastoma.

Authors:  Srishma Sridhar; Batool Al-Moallem; Hawra Kamal; Marta Terrile; Raymond L Stallings
Journal:  Mol Diagn Ther       Date:  2013-04       Impact factor: 4.074

Review 4.  Genetic discoveries and treatment advances in neuroblastoma.

Authors:  Rochelle Bagatell; Susan L Cohn
Journal:  Curr Opin Pediatr       Date:  2016-02       Impact factor: 2.856

Review 5.  Genetic susceptibility to neuroblastoma: current knowledge and future directions.

Authors:  Laura E Ritenour; Michael P Randall; Kristopher R Bosse; Sharon J Diskin
Journal:  Cell Tissue Res       Date:  2018-03-27       Impact factor: 5.249

Review 6.  Retinoblastoma and Neuroblastoma Predisposition and Surveillance.

Authors:  Junne Kamihara; Franck Bourdeaut; William D Foulkes; Jan J Molenaar; Yaël P Mossé; Akira Nakagawara; Andreu Parareda; Sarah R Scollon; Kami Wolfe Schneider; Alison H Skalet; Lisa J States; Michael F Walsh; Lisa R Diller; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

Review 7.  Research progress of neuroblastoma related gene variations.

Authors:  Yanna Cao; Yan Jin; Jinpu Yu; Jingfu Wang; Jie Yan; Qiang Zhao
Journal:  Oncotarget       Date:  2017-03-14

Review 8.  Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer.

Authors:  David M Langenau; Alejandro Sweet-Cordero; Robert Wechsler-Reya; Michael A Dyer
Journal:  Cancer Res       Date:  2015-12-01       Impact factor: 12.701

Review 9.  A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma.

Authors:  Vid Mlakar; Edouard Morel; Simona Jurkovic Mlakar; Marc Ansari; Fabienne Gumy-Pause
Journal:  J Exp Clin Cancer Res       Date:  2021-06-08

10.  Association between NEFL Gene Polymorphisms and Neuroblastoma Risk in Chinese Children: A Two-Center Case-Control Study.

Authors:  Qiang Wu; Zhen-Jian Zhuo; Jixiao Zeng; Jiao Zhang; Jinhong Zhu; Yan Zou; Ruizhong Zhang; Tianyou Yang; Deli Zhu; Jing He; Huimin Xia
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.